A phase II study of afatinib (A) in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab (T) refractory esophagogastric (EG) cancer Meeting Abstract
| Authors: | Janjigian, Y. Y.; Imtiaz, T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Vakiani, E. |
| Abstract Title: | A phase II study of afatinib (A) in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab (T) refractory esophagogastric (EG) cancer |
| Meeting Title: | 105th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 74 |
| Issue: | 19 Suppl. |
| Meeting Dates: | 2014 Apr 5-9 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2014-10-01 |
| Language: | English |
| ACCESSION: | WOS:000349910205055 |
| DOI: | 10.1158/1538-7445.am2014-ct228 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT228 -- 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 05-09, 2014 -- San Diego, CA -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
